Molecular Evidence of Drug Resistance in Asymptomatic Malaria Infections, Myanmar, 2015

Artemisinin resistance containment in Myanmar was initiated in 2011 after artemisinin-resistant Plasmodium falciparum malaria was reported. Molecular evidence suggests that asymptomatic malaria infections harboring drug resistance genes are present among residents of the Myanmar artemisinin resistan...

Descripción completa

Detalles Bibliográficos
Autores principales: Nyunt, Myat Htut, Shein, Thinzar, Zaw, Ni Ni, Han, Soe Soe, Muh, Fauzi, Lee, Seong-Kyun, Han, Jin-Hee, Thant, Kyaw Zin, Han, Eun-Taek, Kyaw, Myat Phone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2017
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382746/
https://www.ncbi.nlm.nih.gov/pubmed/28221121
http://dx.doi.org/10.3201/eid2303.161363
Descripción
Sumario:Artemisinin resistance containment in Myanmar was initiated in 2011 after artemisinin-resistant Plasmodium falciparum malaria was reported. Molecular evidence suggests that asymptomatic malaria infections harboring drug resistance genes are present among residents of the Myanmar artemisinin resistance containment zone. This evidence supports efforts to eliminate these hidden infections.

Ejemplares similares